EGFR-TKI, erlotnib, causes hypomagnesemia, oxidative stress and cardiac dysfunction: Attentuation by NK-1 receptor blockade

Authors

I. Tong Mak, George Washington UniversityFollow
Jay H. Kramer, George Washington University
Joanna J. Chmielinska, George Washington University
Christopher F. Spurney, George Washington UniversityFollow
William B. Weglicki, George Washington University

Document Type

Journal Article

Publication Date

1-2015

Journal

Journal of Cardiovascular Pharmacology

Volume

Volume 65, Issue 1

Inclusive Pages

54-61

DOI

10.1097/FJC.0000000000000163

Keywords

Oxidative Stress--drug effects; Protein Kinase Inhibitors--toxicity; Quinazolines--toxicity; Receptor, Epidermal Growth Factor--antagonists & inhibitors

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Mak, I. T., Kramer, J. H., Chmielinska, J. J., Spurney, C. F., & Weglicki, W. B. (2015). EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: Attenuation by NK-1 receptor blockade. Journal of Cardiovascular Pharmacology, 65(1), 54-61.

Peer Reviewed

1

Open Access

1